Plethico Pharmaceuticals (Delisted) share news and announcements

BSE: 532739

Last traded ₹9.05 on 13 Jun 2016

Delisted on 11 May 2018.

Plethico Pharmaceuticals share news and announcements

488 announcements, routine notices left out, newest first. Page 5 of 10.

Jun 2012
- 29 Jun · Disclosure of Voting Pattern - Clause 35A
  Details of the voting results at the Annual General Meeting held on June 29, 2012. (opens in a new tab)
- 29 Jun · Meeting
  The 19th Annual General Meeting of the Company was held on June 29, 2012, disclosure pursuant to Clause 31 (D) and 35 (A). (For more .... (opens in a new tab)
- 20 Jun · Disclosure
  Shashikant A. Patel has submitted to the Exchange, vide letter dated June 19, 2012, a copy of Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
- 19 Jun · Disclosure
  Plethico Pharmaceuticals Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 (opens in a new tab)
- 19 Jun · Disclosure
  Shashikant Patel has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 19 Jun · Disclosure
  Shashikant Patel has submitted the disclosure under Regulation 13(4A) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE: (opens in a new tab)
- 8 Jun · Corporate action
  Register of Members and Share Transfer Books of the Company will be closed from June 27, 2012 to June 29, 2012 (both days inclusive) for the purpose of Annual General Meeting.
- 8 Jun · Corporate action
  Register of Members & Share Transfer Books of the Company will remain closed from June 27, 2012 to June 29, 2012 for the purpose of ....
- 6 Jun · Disclosure
  Vide letter dated June 04, 2012, a copy of Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
- 5 Jun · Disclosure
  Shashikant Patel has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
May 2012
- 15 May · Results
  Standalone and Consolidated Financial Results for the period ended March 31,2012 alongwith the Limited Review Report. (opens in a new tab)
- 15 May · Results
  Financial Results & a copy of the Limited Review Report for the period ended March 31, 2012. (opens in a new tab)
- 4 May · Board meeting
  Inter-alia to consider, approve and take on record the Un-audited Financial Results of the Company for the quarter ended on March 31, 2012 and any other business with permission of chair.
Apr 2012
Mar 2012
- 5 Mar · Disclosure
  Vide letter dated March 02, 2012, a copy of Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
- 2 Mar · Disclosure
  Shashikant Patel has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 1 Mar · Board meeting
  Board of Directors regret their inability to recommend any dividend for the year ended December 31, 2011, given the Global Financial Scenario and also the impending outcome of the FCCB issued by the Company.
Feb 2012
- 29 Feb · Results
  Plethico Pharmaceuticals Ltd about the Financial Results & a copy of the Auditors Report for the period ended December 31, 2011. (opens in a new tab)
- 29 Feb · Board meeting
  Board of Directors of the Company at its meeting held on February 29, 2012, inter alia, has transacted the following : - The ....
- 29 Feb · Results
  Standalone and Consolidated Financial Results for the period ended December 31,2011. (opens in a new tab)
- 23 Feb · Disclosure
  Declaration under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
- 22 Feb · Disclosure
  Shashikant Patel has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 17 Feb · Board meeting
  Inter-alia : (1) To Consider, approve and take on record the Audited Financial Results of the Company for the quarter/ year ended on December 31, 2011; and (2) Recommendation of dividend on Equity Shares for the year ended December 31, 2011, if any. (3) Any other matter with the permission of chair.
- 17 Feb · Board meeting
  Meeting of the Board of Directors of the Company will be held on February 29, 2012, inter alia: 1. To consider, approve and take ....
- 7 Feb · Disclosure
  Intimation under Regulation 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
- 7 Feb · Disclosure
  Shashikant Patel has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
Jan 2012
Dec 2011
Nov 2011
- 17 Nov · Natrol Partners With Bikram Yoga to introduce Vedic Mantra Ayurvedic Nutritional Supplements
  Press Release of its wholly owned subsidiary Natrol Inc., USA titled "Natrol Partners With Bikram Yoga to introduce Vedic Mantra Ayurvedic .... (opens in a new tab)
- 17 Nov · Business
  Vide its letter dated November 17, 2011 regarding a press release, titled ."Natrol Partners With Bikram Yoga to introduce Vedic Mantra Ayurvedic Nutritional Supplements". (opens in a new tab)
- 17 Nov · Business
  Natro Tonalin CLA being the leading brand product of Natrol Inc. USA has won the "Better Nutrition's 2011 Best of Supplements" award. ....